Capital Flow Monitor · Sponsors · CIK 1787352
Nuclein, LLC
8305 CROSS PARK DR, AUSTIN, TX, 78754 · 512-879-3301
Biotechnology · Limited Liability Company· inc. TEXAS true
Fit score
—
Offering
$25.0M
Sold
$19.1M
% sold
76.3%
Investors
49
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | D | 506(b) | $11.1M | $1.3M | 11.7% | 2 | EDGAR ↗ |
| 2026-04-27 | D/A ·current | 506(b) | $25.0M | $19.1M | 76.3% | 49 | EDGAR ↗ |
| 2026-02-05 | D/A | 506(b) | $15.0M | $9.4M | 62.6% | 34 | EDGAR ↗ |
| 2025-12-17 | D/A | 506(b) | $20.0M | $14.9M | 74.5% | 42 | EDGAR ↗ |
| 2025-10-14 | D/A | 506(b) | $15.0M | $9.8M | 65.2% | 37 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Alan Blake — Executive Officer / Director, Austin, TX
- Richard Crockett — Director, Austin, TX
- William Cunningham — Director, Austin, TX
- Douglas Bryant — Director, Austin, TX
- Sanjay Chandra — Director, Austin, TX
- H. David Shockley — Director, Austin, TX
- Walter Narajowski — Director, Austin, TX
- Jeffrey Stukuls — Executive Officer, Austin, TX
Placement agents
- Tpeg Securities, Llc · 2 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.